Panel to Review Glaxo, Aventis Pasteur Vaccine Data
02/18/2005
Federal Register Notice: FDA’s Vaccines and Related Biological Products Advisory Committee will meet 3/15, from 8:30 a.m. until about 5:40 p.m. at the Holiday Inn Select Bethesda, 8120 Wisconsin Ave., Bethesda, MD. The committee will review safety and immunogenicity for two Tetanus Toxoid, Reduced Diptheria Toxoid and Acellular Pertussis Vaccine, Absorbed (Tdap) vaccines. In the morning the committee will review safety and immunogenicity data for GlaxoSMithKline’s product and data for Aventis Pasteur’s product in the afternoon. Contact Christine Walsh or Denise Royster, (301) 827-0314. To view this notice, click here.
